Ironwood Pharmaceuticals (STU:I76) Long-Term Debt : €435.6 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Ironwood Pharmaceuticals Long-Term Debt?

Ironwood Pharmaceuticals's Long-Term Debt for the quarter that ended in Mar. 2024 was €435.6 Mil.

Ironwood Pharmaceuticals's quarterly Long-Term Debt declined from Sep. 2023 (€490.2 Mil) to Dec. 2023 (€456.9 Mil) and declined from Dec. 2023 (€456.9 Mil) to Mar. 2024 (€435.6 Mil).

Ironwood Pharmaceuticals's annual Long-Term Debt increased from Dec. 2021 (€298.5 Mil) to Dec. 2022 (€374.1 Mil) and increased from Dec. 2022 (€374.1 Mil) to Dec. 2023 (€456.9 Mil).

Ironwood Pharmaceuticals Long-Term Debt Historical Data

The historical data trend for Ironwood Pharmaceuticals's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ironwood Pharmaceuticals Long-Term Debt Chart

Ironwood Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

367.20

353.67

298.54

374.06

456.95

Ironwood Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															370.47	551.93	490.18	456.95	435.60

Ironwood Pharmaceuticals (STU:I76) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Ironwood Pharmaceuticals Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Ironwood Pharmaceuticals's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Ironwood Pharmaceuticals (STU:I76) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ironwood Pharmaceuticals Inc (STU:I76) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

IRWD:USA I76:Germany

Address

100 Summer Street, Suite 2300, Boston, MA, USA, 02110

Website

https://www.ironwoodpharma.com

Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Ironwood Pharmaceuticals (STU:I76) Headlines

No Headlines